Veracyte VCYT
NASDAQ VCYT
$43.00 +1.48 (+3.56%)
As of: Sep 22, 2026 · 11:39 AM EDT

Veracyte (VCYT) Gains from Investment Securities (2013 - 2026)

Veracyte's (VCYT) quarterly Gains from Investment Securities came in at -$318000.0 in Q2 2026, up 65.62% year-over-year from -$192003.9 in Q2 2025, and up 9.14% quarter-over-quarter from -$350000.0 in Q1 2026.

Analysis

Veracyte (VCYT) Gains from Investment Securities (2013 - 2026) Analysis & Trends

Veracyte has disclosed Gains from Investment Securities across 8 years of filings, most recently posting -$318000.0 for Q2 2026.

  • In Q2 2026, Gains from Investment Securities rose 65.62% year-over-year to -$318000.0; the TTM figure through Jun 2026 stood at -$13.1 million (down 730.73% YoY), while the FY2025 annual figure was -$15.3 million, down 805.81% from the prior year.
  • Gains from Investment Securities came in at -$318000.0 for Q2 2026 at Veracyte, up from -$350000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $925000.0 in Q4 2024 to a low of -$12.6 million in Q4 2025.
  • Average Gains from Investment Securities over 5 years is -$1.1 million, with a median of -$13500.0 recorded in 2022.
  • Year-over-year, Gains from Investment Securities surged 690.6% in 2024 and tumbled 39180.0% in 2025.
  • Over 5 years, Gains from Investment Securities stood at $234000.0 in 2022, then plunged by 50.0% to $117000.0 in 2023, then surged by 690.6% to $925000.0 in 2024, then tumbled by 1460.22% to -$12.6 million in 2025, then jumped by 97.47% to -$318000.0 in 2026.
  • Per Business Quant data, the three most recent Gains from Investment Securities figures were -$318000.0 in Q2 2026, -$350000.0 in Q1 2026, and -$12.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 Veracyte 3.20 Bn 2.90 Bn 108.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -318,000.00
Mar 31, 2026 -350,000.00
Dec 31, 2025 -12.58 Mn
Sep 30, 2025 166,000.00
Jun 30, 2025 -925,000.00
Mar 31, 2025 -1.95 Mn
Dec 31, 2024 925,000.00
Sep 30, 2024 379,000.00
Jun 30, 2024 858,000.00
Mar 31, 2024 5,000.00
Dec 31, 2023 117,000.00
Sep 30, 2023 -5.16 Mn
Jun 30, 2023 141,000.00
Mar 31, 2023 -485,000.00
Dec 31, 2022 234,000.00
Sep 30, 2022 -32,000.00
Jun 30, 2022 -79,000.00
Mar 31, 2022 31,000.00
Dec 31, 2021 507,000.00
Sep 30, 2021 56,000.00
API Access

Veracyte Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=VCYT&period=max&api_key=YOUR_API_KEY